STOCK TITAN

Zivo Bioscience Stock Price, News & Analysis

ZIVOW OTC Link

Company Description

Zivo Bioscience (OTC Link: ZIVOW) is a publicly traded biotechnology company in the Healthcare sector.

ZIVOW stock has declined 98.5% over the past year. Shares last traded at $0.0155.

On a trailing twelve-month basis, Zivo Bioscience reported revenue of $157K and diluted earnings per share of $-4.23.

This page provides a comprehensive overview of ZIVOW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-98.47%
Performance 1 year

Zivo Bioscience (ZIVOW) stock last traded at $0.0155. Over the past 12 months, the stock has lost 98.5%.

ZIVOW Rankings

SEC Filings

Zivo Bioscience has filed 10 recent SEC filings, including 8 Form 4, 2 Form SCHEDULE 13D/A. The most recent filing was submitted on April 24, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ZIVOW SEC filings →

Financial Highlights

Zivo Bioscience generated $157K in revenue over the trailing twelve months, retaining a 31.1% gross margin. Diluted earnings per share stood at $-4.23. The company generated -$4.3M in operating cash flow. With a current ratio of 0.80, short-term liquidity bears monitoring.

$157K
Revenue (TTM)
-$4.3M
Operating Cash Flow
$49K
Gross Profit (TTM)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Zivo Bioscience (ZIVOW) currently stands at 1.8 thousand shares, representing 0.1% of the float. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Zivo Bioscience (ZIVOW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 97.4% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.

ZIVOW Company Profile & Sector Positioning

Zivo Bioscience (ZIVOW) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.

Investors comparing ZIVOW often look at related companies in the same sector, including Oncoinvent ASA (BRRGF), Zivo Bioscience Inc (ZIVO), Relief Hldg (RLFTF), MindMaze Therapeutics Holding SA (RLFTY), and Covalon Technologies Ltd (CVALF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ZIVOW's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Zivo Bioscience (ZIVOW)?

The current stock price of Zivo Bioscience (ZIVOW) is $0.01545 as of April 6, 2026.

What is the revenue (TTM) of Zivo Bioscience (ZIVOW) stock?

The trailing twelve months (TTM) revenue of Zivo Bioscience (ZIVOW) is $157K.

What is the earnings per share (EPS) of Zivo Bioscience (ZIVOW)?

The diluted earnings per share (EPS) of Zivo Bioscience (ZIVOW) is $-4.23 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Zivo Bioscience (ZIVOW)?

The operating cash flow of Zivo Bioscience (ZIVOW) is -$4.3M. Learn about cash flow.

What is the gross margin of Zivo Bioscience (ZIVOW)?

The gross profit margin of Zivo Bioscience (ZIVOW) is 31.1%. Learn about gross margins.

What is the current ratio of Zivo Bioscience (ZIVOW)?

The current ratio of Zivo Bioscience (ZIVOW) is 0.80, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Zivo Bioscience (ZIVOW)?

The gross profit of Zivo Bioscience (ZIVOW) is $49K on a trailing twelve months (TTM) basis.